{
    "Relevant Biomarkers": [
        {
            "BioMarker": "CHD6",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "PTPN11",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "NRAS",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Fusion not detected"
        },
        {
            "BioMarker": "HBA2",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Fusion not detected"
        },
        {
            "BioMarker": "CALR",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "Mismatch repair status",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Negative| 2+, 64%"
        },
        {
            "BioMarker": "ER",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Negative| 1+, 10%"
        },
        {
            "BioMarker": "AR",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Negative| 1+, 83%"
        }
    ],
    "Genomic Signatures": [
        {
            "BioMarker": "Microsatellite instability",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "High"
        },
        {
            "BioMarker": "Tumor mutational burden",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "17 mutations/Mb High"
        },
        {
            "BioMarker": "Genomic loss of heterozygosity (LOH)",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "High - 39% of tested genmoic segments exhibit LOH"
        }
    ],
    "Genes Tested with Pathogenic Alterations": [
        {
            "Gene": "EZH2",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Benign",
            "Protien Alteration": "p.L239R",
            "Exon": 12,
            "DNA Alteration": "c.716T>G",
            "Allele Frequency %": "3.69"
        },
        {
            "Gene": "CSF3R",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": "p.N713_A714insKGKGGG",
            "Exon": 20,
            "DNA Alteration": "c.1924A>C",
            "Allele Frequency %": "1.0"
        },
        {
            "Gene": "PTCH1",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": "p.E17K",
            "Exon": 2,
            "DNA Alteration": "c.49G>A",
            "Allele Frequency %": "26.93"
        },
        {
            "Gene": "PRKCA",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": "p.S346P",
            "Exon": 13,
            "DNA Alteration": "G",
            "Allele Frequency %": "23.11"
        },
        {
            "Gene": "JAK2",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Pathogenic",
            "Protien Alteration": "p.F332V",
            "Exon": 2,
            "DNA Alteration": "G",
            "Allele Frequency %": "12.13"
        },
        {
            "Gene": "RNF43",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Benign",
            "Protien Alteration": "p.V842I",
            "Exon": 6,
            "DNA Alteration": "c.2325_2326ins12",
            "Allele Frequency %": "9.83"
        }
    ]
}